Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, and the Massachusetts Life Sciences Center today announced the opening of Promedior’s new office and laboratory space at 101 Hartwell Avenue, Lexington, Mass.
Consolidating all of its operations, the new facility will serve as the company’s headquarters and completes the corporate move from the suburbs of Philadelphia, Penn. Promedior’s new facility includes state-of-the-art laboratories to support product development and commercialization of the company’s novel Pentraxin-2 therapeutics to treat fibrosis, including a number of rare diseases such as idiopathic pulmonary fibrosis (IPF) and myelofibrosis.
